Dec 02, 2021 / 07:40PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Thank you, guys, for joining us. Pleasure to have the management team from Gilead with us. I always joke about it, but the last in-person event I hosted with any company -- well, actually I just did one with Lilly recently on the road in Boston and New York. But the one prior to that, pre-pandemic, was with Merdad in San Francisco. And I remember this was late February 2020, so I guess we've built up a lot of T cells during that.
Merdad V. Parsey - Gilead Sciences, Inc. - Chief Medical Officer
We can only hope, right?
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
That's right. Well, listen, thank you guys for being here. Let me first turn it over to you, perhaps, Andy, to kick things off. Maybe lay the top priorities you have on your mind, and we'll jump right in.
Andrew D. Dickinson - Gilead
Gilead Sciences Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot